107 related articles for article (PubMed ID: 28544586)
1. Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines.
Ammazzalorso A; De Lellis L; Florio R; Bruno I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Perconti S; Verginelli F; Cama A; Amoroso R
Chem Biol Drug Des; 2017 Nov; 90(5):1029-1035. PubMed ID: 28544586
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent and selective PPARα/δ dual antagonists and initial biological studies.
Jacintho JD; Baccei CS; Bravo Y; Broadhead A; Chen A; Correa L; Fischer K; Laffitte B; Lee C; Lorrain DS; Messmer D; Prasit P; Stebbins KJ; Stock NS
Bioorg Med Chem Lett; 2019 Feb; 29(3):503-508. PubMed ID: 30594433
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptors-α and -γ, and cAMP-mediated pathways, control retinol-binding protein-4 gene expression in brown adipose tissue.
Rosell M; Hondares E; Iwamoto S; Gonzalez FJ; Wabitsch M; Staels B; Olmos Y; Monsalve M; Giralt M; Iglesias R; Villarroya F
Endocrinology; 2012 Mar; 153(3):1162-73. PubMed ID: 22253419
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
5. Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway.
Qu Q; Qu J; Guo Y; Zhou BT; Zhou HH
Anticancer Drugs; 2014 Oct; 25(9):1016-27. PubMed ID: 25075794
[TBL] [Abstract][Full Text] [Related]
6. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ).
Szychowski KA; Leja ML; Kaminskyy DV; Kryshchyshyn AP; Binduga UE; Pinyazhko OR; Lesyk RB; Tobiasz J; Gmiński J
Eur J Med Chem; 2017 Dec; 141():162-168. PubMed ID: 29031063
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro evaluation, and molecular modeling investigation of benzenesulfonimide peroxisome proliferator-activated receptors α antagonists.
Ammazzalorso A; Carrieri A; Verginelli F; Bruno I; Carbonara G; D'Angelo A; De Filippis B; Fantacuzzi M; Florio R; Fracchiolla G; Giampietro L; Giancristofaro A; Maccallini C; Cama A; Amoroso R
Eur J Med Chem; 2016 May; 114():191-200. PubMed ID: 26974385
[TBL] [Abstract][Full Text] [Related]
8. Benzothiazole-based N-(phenylsulfonyl)amides as a novel family of PPARα antagonists.
Ammazzalorso A; Giancristofaro A; D'Angelo A; Filippis BD; Fantacuzzi M; Giampietro L; Maccallini C; Amoroso R
Bioorg Med Chem Lett; 2011 Aug; 21(16):4869-72. PubMed ID: 21742490
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
11. Effects of the environmental contaminants DEHP and TCDD on estradiol synthesis and aryl hydrocarbon receptor and peroxisome proliferator-activated receptor signalling in the human granulosa cell line KGN.
Ernst J; Jann JC; Biemann R; Koch HM; Fischer B
Mol Hum Reprod; 2014 Sep; 20(9):919-28. PubMed ID: 24950685
[TBL] [Abstract][Full Text] [Related]
12. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activity.
Porcelli L; Gilardi F; Laghezza A; Piemontese L; Mitro N; Azzariti A; Altieri F; Cervoni L; Fracchiolla G; Giudici M; Guerrini U; Lavecchia A; Montanari R; Di Giovanni C; Paradiso A; Pochetti G; Simone GM; Tortorella P; Crestani M; Loiodice F
J Med Chem; 2012 Jan; 55(1):37-54. PubMed ID: 22081932
[TBL] [Abstract][Full Text] [Related]
14. Regulation of steroidogenic function of mouse Leydig cells: G-coupled membrane estrogen receptor and peroxisome proliferator-activated receptor partnership.
Gorowska-Wojtowicz E; Dutka P; Kudrycka M; Pawlicki P; Milon A; Plachno BJ; Tworzydlo W; Pardyak L; Kaminska A; Hejmej A; Bilinska B; Kotula-Balak M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30149370
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Richard CL; Blay J
Int J Oncol; 2007 May; 30(5):1215-22. PubMed ID: 17390024
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cytotoxicity of benzoxazole-based PPARα/γ antagonists in colorectal cancer cell lines.
Moreno-Rodríguez N; Laghezza A; Cerchia C; Sokolova DV; Spirina TS; De Filippis B; Romanelli V; Recio R; Fernández I; Loiodice F; Pokrovsky VS; Ammazzalorso A; Lavecchia A
Arch Pharm (Weinheim); 2024 May; ():e2400086. PubMed ID: 38807029
[TBL] [Abstract][Full Text] [Related]
18. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery.
Romano MR; Lograno MD
Eur J Pharmacol; 2012 May; 683(1-3):197-203. PubMed ID: 22429572
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
Almahmoud S; Elix CC; Jones JO; Hopkins CR; Vennerstrom JL; Zhong HA
Bioorg Med Chem; 2021 Sep; 46():116368. PubMed ID: 34433102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
